Digital Signal Processing Reference
In-Depth Information
[426] Coakley, F.V., Qayyum, A., and Kurhanewicz, J., Magnetic resonance
imaging and spectroscopic imaging of prostate cancer, J. Urology, 170
(Suppl.), 69 - 76, 2003.
[427] Kurhanewicz, J., Swanson, M.G., Wood, P.J., and Vigneron, D.B.,
Magnetic resonance imaging and spectroscopic imaging: improved
patient selection and potential for metabolic intermediate endpoints in
prostate cancer chemoprevention trials, Urology, 57 (Suppl. 4A), 124 -
128, 2001.
[428] MuellerLisse, U.G., Swanson, M.G., Vigneron, D.B., Hricak, H.,
Bessette, A., Males, R.G., Wood, P.J., Noworolski, S., Nelson, S.J.,
Barken, I., Carroll, P.R., and Kurhanewicz, J., Timedependent effects
of hormonedeprivation therapy on prostate metabolism as detected
by combined magnetic resonance imaging and 3D magnetic resonance
spectroscopic imaging, Magn. Reson. Med., 46, 49 - 57, 2001.
[429] Westphalen, A.C., McKenna, D.A., Kurhanewicz, J., and Coakley,
F.V., Role of magnetic resonance imaging and magnetic resonance
spectroscopic imaging before and after radiotherapy for prostate
cancer, J. Endourol., 22, 789 - 794, 2008.
[430] Cirillo, S., Petracchini, M., D'Urso, L., Dellamonica, P., Illing, R.,
Regge, D., and Muto, G., Endorectal magnetic resonance imaging and
magnetic resonance spectroscopy to monitor the prostate for residual
disease or local cancer recurrence after transrectal highintensity
focused ultrasound, Br. J. Urol. Int., 102, 452 - 458, 2008.
[431] Pucar, D., Sella, T., and Schoder, H., The role of imaging in the
detection of prostate cancer local recurrence after radiation therapy
and surgery, Curr. Opinion Urol., 18, 87 - 97, 2008.
[432] Pickett, B., Kurhanewicz, J., Pouliot, J., Weinberg, V., Shinohara, K.,
Coakley, F., and Roach, M., Threedimensional conformal external
beam radiotherapy compared with permanent prostate implantation in
lowrisk prostate cancer based on endorectal magnetic resonance
spectroscopy imaging and prostatespecific antigen level, Int. J.
Radiat. Oncol. Biol. Phys., 65, 65 - 72, 2006.
[433] Pouliot, J., Kim, Y., Lessard, E., Hsu, I.C., Vigneron, D.B., and
Kurhanewicz, J., Inverse planning for HDR prostate brachytherapy
used to boost dominant intraprostatic lesions defined by magnetic
resonance spectroscopy imaging, Int. J. Radiat. Oncol. Biol. Phys., 59,
1196 - 1207, 2004.
[434] Joseph, T., McKenna, D.A., Westphalen, A.C., Coakley, F.V., Zhao,
S., Lu, Y., Hsu, I.C., Roach, M., and Kurhanewicz, J., Pretreatment
endorectal magnetic resonance imaging and magnetic resonance
spectroscopic imaging features of prostate cancer as predictors of
Search WWH ::
Custom Search